Transforming growth factor-β1 modulates insulin-like growth factor binding protein-4 expression and proteolysis in cultured periosteal explants

Growth Hormone and IGF Research

Volumn 20, Issue 2, 2010, Pages 81-86

  Gonzalez, Carlos ^a   Auw Yang, Kiem G ^a   Schwab, Joseph H ^a   Fitzsimmons, James S ^a   Reinholz, Monica M ^a   Resch, Zachary T ^a   Bale, Laurie K ^a   Clemens, Victoria R ^a   Conover, Cheryl A ^a   O'Driscoll, Shawn W ^a   Reinholz, Gregory G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cartilage; Chondrocyte; Insulin like growth factor binding protein 4; Insulin like growth factor I; Periosteum; Pregnancy associated plasma protein A; Transforming growth factor beta

Indexed keywords

MESSENGER RNA; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CHONDROGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EXPLANT; GENE EXPRESSION REGULATION; NONHUMAN; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS REGULATION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE CULTURE;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; ORGAN CULTURE TECHNIQUES; PERIOSTEUM; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROTEIN PROCESSING, POST-TRANSLATIONAL; RABBITS; RNA, MESSENGER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77949654120     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.06.002     Document Type: Article

References (49)

1. O'Driscoll S.W., Salter R.B. The induction of neochondrogenesis in free intra-articular periosteal autografts under the influence of continuous passive motion. An experimental investigation in the rabbit. J. Bone Joint Surg. 1984, 66A:1248-1257.
2. O'Driscoll S.W., Keeley F.W., Salter R.B. Durability of regenerated articular cartilage produced by free autogenous periosteal grafts in major full-thickness defects in joint surfaces under the influence of continuous passive motion. A follow-up report at one year. J. Bone Joint Surg. 1988, 70A:595-606.
3. O'Driscoll S.W., Salter R.B. The repair of major osteochondral defects in joint surfaces by neochondrogenesis using autogenous osteoperiosteal grafts stimulated by continuous passive motion. An experimental investigation in the rabbit. Clin. Orthop. 1986, 208:131-140.
4. O'Driscoll S.W., Keeley F.W., Salter R.B. The chondrogenic potential of free autogenous periosteal grafts for biological resurfacing of major full-thickness defects in joint surfaces under the influence of continuous passive motion. An experimental investigation in the rabbit. J. Bone Joint Surg. 1986, 68A:1017-1035.
5. O'Driscoll S.W. Articular cartilage regeneration using periosteum. Clin. Orthop. 1999, 367(Suppl.):186-203.
6. Nakahara H., Bruder S.P., Haynesworth S.E., Holecek J.J., Baber M.A., Goldberg V.M., et al. Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 1990, 11:181-188.
7. O'Driscoll S.W., Fitzsimmons J.S. The role of periosteum in cartilage repair. Clin. Orthop. 2001, S190-S207.
8. Nakahara H., Goldberg V.M., Caplan A.I. Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J. Orthop. Res. 1991, 9:465-476.
9. O'Driscoll S.W., Recklies A.D., Poole A.R. Chondrogenesis in periosteal explants. An organ culture model for in vitro study. J. Bone Joint Surg. Am. 1994, 76:1042-1051.
10. Hutmacher D.W., Sittinger M. Periosteal cells in bone tissue engineering. Tissue Eng. 2003, 9(Suppl. 1):S45-S64.
11. Stevens M.M., Marini R.P., Schaefer D., Aronson J., Langer R., Shastri V.P. In vivo engineering of organs: the bone bioreactor. Proc. Natl. Acad. Sci. USA 2005, 102:11450-11455.
12. O'Driscoll S.W., Salter R.B. The repair of major osteochondral defects in joint surfaces by neochondrogenesis with autogenous osteoperiosteal grafts stimulated by continuous passive motion. An experimental investigation in the rabbit. Clin. Orthop. Relat. Res. 1986, 131-140.
13. Mardones R.M., Reinholz G.G., Fitzsimmons J.S., Zobitz M.E., An K.N., Lewallen D.G., et al. Development of a biologic prosthetic composite for cartilage repair. Tissue Eng. 2005, 11:1368-1378.
14. Knothe U.R., Springfield D.S. A novel surgical procedure for bridging of massive bone defects. World J. Surg. Oncol. 2005, 3:7.
15. De Bari C., Dell'Accio F., Vanlauwe J., Eyckmans J., Khan I.M., Archer C.W., et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum. 2006, 54:1209-1221.
16. Tonna E.A. An autoradiographic evaluation of the aging cellular phase of mouse skeleton using tritiated glycine. J. Gerontal. 1964, 19.
17. Ito Y., Fitzsimmons J.S., Sanyal A., Mello M.A., Mukherjee N., O'Driscoll S.W. Localization of chondrocyte precursors in periosteum. Osteoarthritis Cartilage 2001, 9:215-223.
18. O'Driscoll S.W., Saris D.B.F., Ito Y., Fitzsimmons J.S. The chondrogenic potential of periosteum decreases with age. J. Orthop. Res. 2001, 19:95-103.
19. Miura Y., Fitzsimmons J.S., Commisso C.N., Gallay S.H., O'Driscoll S.W. Enhancement of periosteal chondrogenesis in vitro: dose-response for transforming growth factor-beta 1 (TGF-β1). Clin. Orthop. 1994, 301:271-280.
20. Fukumoto T., Sperling J.W., Sanyal A., Fitzsimmons J.S., Reinholz G.G., Conover C.A., et al. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 2003, 11:55-64.
21. Fitzsimmons J.S., Sanyal A., Gonzalez C., Fukumoto T., Clemens V.R., O'Driscoll S W., et al. Serum-free media for periosteal chondrogenesis in vitro. J. Orthop. Res. 2004, 22:716-725.
22. Davis C.M., Miura Y., Sarkar G., Bolander M.E., Fitzsimmons J.S., O'Driscoll S.W. Expression of cartilage-specific genes during neochondrogenesis in periosteal explants. Biomed. Res. 2000, 21:9-15.
23. Reinholz G.G., Fitzsimmons J.S., Casper M.E., Ruesink T.J., Chung H.W., Schagemann J.C., et al. Rejuvenation of periosteal chondrogenesis using local growth factor injection. Osteoarthritis Cartilage 2009, 17:723-734.
24. Morales T.I. The role and content of endogenous insulin-like growth factor-binding proteins in bovine articular cartilage. Arch. Biochem. Biophys. 1997, 343:164-172.
25. De Los Rios P., Hill D.J. Expression and release of insulin-like growth factor binding proteins in isolated epiphyseal growth plate chondrocytes from the ovine fetus. J. Cell Physiol. 2000, 183:172-181.
26. Tsukazaki T., Usa T., Matsumoto T., Enomoto H., Ohtsuru A., Namba H., et al. Effect of transforming growth factor-beta on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. Exp. Cell Res. 1994, 215:9-16.
27. Ortiz C.O., Chen B.K., Bale L.K., Overgaard M.T., Oxvig C., Conover C.A. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. J. Bone Miner. Res. 2003, 18:1066-1072.
28. Shimasaki S., Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Progr. Growth Factor Res. 1991, 3:243-266.
29. Olney R.C., Tsuchiya K., Wilson D.M., Mohtai M., Maloney W.J., Schurman D.J., et al. Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4. J. Clin. Endocrinol. Metab. 1996, 81:1096-1103.
30. Mohan S., Bautista C.M., Wergedal J., Baylink D.J. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. Proc. Natl. Acad. Sci. USA 1989, 86:8338-8342.
31. Mohan S., Nakao Y., Honda Y., Landale E., Leser U., Dony C., et al. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J. Biol. Chem. 1995, 270:20424-20431.
32. Durham S.K., De Leon D.D., Okazaki R., Riggs B.L., Conover C.A. Regulation of insulin-like growth factor (IGF)-binding protein-4 availability in normal human osteoblast-like cells: role of endogenous IGFs. J. Clin. Endocrinol. Metab. 1995, 80:104-110.
33. Qin X., Byun D., Strong D.D., Baylink D.J., Mohan S. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs. J. Bone Miner. Res. 1999, 14:2079-2088.
34. Durham S.K., Kiefer M.C., Riggs B.L., Conover C.A. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology. J. Bone Miner. Res. 1994, 9:111-117.
35. Kanzaki S., Hilliker S., Baylink D.J., Mohan S. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 1994, 134:383-392.
36. Lawrence J.B., Oxvig C., Overgaard M.T., Sottrup-Jensen L., Gleich G.J., Hays L.G., et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc. Natl. Acad. Sci. USA 1999, 96:3149-3153.
37. Conover C.A., Kiefer M.C., Zapf J. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J. Clin. Invest. 1993, 91:1129-1137.
38. Conover C.A., Durham S.K., Zapf J., Masiarz F.R., Kiefer M.C. Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J. Biol. Chem. 1995, 270:4395-4400.
39. Sanyal A., O'Driscoll S.W., Fitzsimmons J.S., Bolander M.E., Sarkar G. Gene digging. A method for obtaining species-specific sequence based on conserved segments of nucleotides in open reading frames. Mol. Biotechnol. 1998, 10:223-230.
40. Qin X., Byun D., Lau K.H., Baylink D.J., Mohan S. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Arch. Biochem. Biophys. 2000, 379:209-216.
41. Torring O., Firek A.F., Heath 3rd H., Conover C.A. Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3′,5′-monophosphate-dependent mechanism. Endocrinology 1991, 128:1006-1014.
42. Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 1986, 154:138-143.
43. Durham S.K., Riggs B.L., Conover C.A. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta. J. Clin. Endocrinol. Metab. 1994, 79:1752-1758.
44. Miller B.S., Bronk J.T., Nishiyama T., Yamagiwa H., Srivastava A., Bolander M.E., et al. Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice. J. Endocrinol. 2007, 192:505-513.
45. Fernihough J.K., Billingham M.E., Cwyfan-Hughes S., Holly J.M. Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis Rheum. 1996, 39:1556-1565.
46. Martel-Pelletier J., Di Battista J.A., Lajeunesse D., Pelletier J.P. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm. Res. 1998, 47:90-100.
47. Iwanaga H., Matsumoto T., Enomoto H., Okano K., Hishikawa Y., Shindo H., et al. Enhanced expression of insulin-like growth factor-binding proteins in human osteoarthritic cartilage detected by immunohistochemistry and in situ hybridization. Osteoarthritis Cartilage 2005, 13:439-448.
48. Dore S., Pelletier J.P., DiBattista J.A., Tardif G., Brazeau P., Martel-Pelletier J. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins. Arthritis Rheum. 1994, 37:253-263.
49. Martin J.A., Ellerbroek S.M., Buckwalter J.A. Age-related decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins. J. Orthop. Res. 1997, 15:491-498.